Stoke Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Stoke Therapeutics Inc 's ROA in the second quarter of 2026?
Stoke Therapeutics Inc recorded a cumulative net loss of $-208 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -51.44%.

However, within the Healthcare sector 571 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 3169 to 3817.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	2.18 %	8.56 %	53 %	22.36 %	25.28 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-208	-170	-7	41	52
Return On Assets (TTM)	-51.44 %	-42.23 %	-1.75 %	11.36 %	15.41 %
STOK's Total Ranking	# 3817	# 3169	# 537	# 326	# 333
Total Assets (TTM) in million	394	443	418	361	386
Seq. Total Assets Change	-11.12 %	5.94 %	15.96 %	-6.41 %	-5.58 %
Seq. Net Income Change	-	-	-	-	-

STOK's 5 Years Annual ROA >> Back to STOK Management Effectiveness >> Compare STOK ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 249
Sector	# 572
Overall	# 3911

Return On Assets Statistics
High	Average	Low
15.72 %	-26.57 %	-51.46 %
		(Jun 30 2026)

Financial Statements
Stoke Therapeutics Inc 's Assets	$ 394 million	STOK's Balance sheet
Stoke Therapeutics Inc 's Income	$ -62 million	Quarterly STOK's Income Statement
STOK's Income by Division		See STOK's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	91.85 %	19.77 %	-10.83 %	7.43 %	-19.99 %
Total Assets in million	525	273	228	256	238
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-7	-89	-105	-101	-86
Annual Return On Assets	-1.31 %	-32.54 %	-45.85 %	-39.47 %	-36 %

STOK's 5 Years Annual ROA >> Back to STOK Management Effectiveness >> Compare STOK ROA to its Competitors

More Return On Assets Ratios
STOK's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STOK's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STOK's Competitors
Subscribers only: Roa for Stoke Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for STOK's Customers

You may also want to know
STOK's Roi	STOK's Inventory Turnover Ratio	STOK's Growth Rates	STOK's Dividend Comparisons
	STOK's Profitability Ratios	STOK's Asset Turnover Ratio	STOK's Dividend Growth
STOK's Roe	STOK's Valuation Ratios	STOK's Financial Strength Ratios	STOK's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T18:57:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.